#1 Ranked Children’s Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
Children’s Hospital Boston is home to the world’s most extensive research enterprise at a pediatric hospital.
We also have many partnerships with the top research, biotech and health care organizations, and we work together to find innovative ways to improve kids’ health and treat life-threatening diseases.
Hope for regenerating kidney cells
Jordan Kreidberg, MD, PhD, director of Developmental Biology and Stem Cell Research in Children's Division of Nephrology, conducts research on kidney stem cells (the cells that turn into kidneys as the fetus develops) in an effort to find new treatments for conditions including:
Kreidberg and his team have found the genes in these cells that tell the kidneys how to grow, and hope to use this information to grow new functional kidney cells to use in transplantation.
Study sheds new light on focal segmental glomerulosclerosis (FSGS)
Finding treatments for FSGS, a poorly understood condition that leads to end-stage renal disease, and in some cases, prevents the possibility of transplant, is recognized as one the great challenges in the field. A research team led by Elizabeth Brown, MD, of Children's Division of Nephrology, working in the laboratory of Martin Pollak, MD, of the Renal Division at Brigham and Women's Hospital, has identified an important gene associated with the disease.
Other genes have been linked with FSGS, but they consider INF2 to be an important discovery. Mutations on this gene seem to affect larger numbers of families than those on previously discovered genes, and may be more relevant in understanding how the disease originates physiologically – which could lead to more effective treatment.
Our researchers are also involved in studies designed to improve post-transplant treatment for children with FSGS and familial HUS and slow the progression of chronic kidney disease.
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”